Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024

By afschroeder • September 17, 2026

Zheng D, Nold T, Ramakrishnan N, Kim K, Tomassetti S. Real-World Management of Chronic Myelogenous Leukemia in an Underserved Patient Cohort at a Los Angeles Safety-Net Health System: Tyrosine Kinase Inhibitor Treatment Patterns and Outcomes From 2015 to 2024. Cancer Med. 2026 Sep;15(9):e72223. doi: 10.1002/cam4.72223. PMID: 42745440.

Tags: chronic myelogenous leukemia, county, Fellow, General Internal Medicine, Harbor UCLA, Hematology/Oncology, Hispanic, Publications, Resident, safety‐net, underserved

Response to Spillover Effects in Randomized Evaluations of Translational AI

Leuchter RK, Turner WB, Ouyang D. Response to Spillover Effects in Randomized Evaluations of Translational AI. NEJM AI. 2026 Mar;3(3):AIp2600014. doi: 10.1056/AIp2600014. Epub 2026 Feb[...]

Letter: Spillover Effects in Randomized Evaluations of Translational AI

Mann S, Berdahl CT. Letter: Spillover Effects in Randomized Evaluations of Translational AI. NEJM AI. 2026 Mar;3(3):AIp2501326. doi: 10.1056/AIp2501326. Epub 2026 Feb 26. PMID: 42932501.

The Consent Gap in Ambient AI Scribes – Reply

Lukac PJ, Cheng EM, Mafi JN. The Consent Gap in Ambient AI Scribes - Reply. NEJM AI. 2026 Sep;3(9):AIltr2600683. doi: 10.1056/AIltr2600683. Epub 2026 Aug 27.[...]